These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37021359)

  • 1. Point estimation for adaptive trial designs II: Practical considerations and guidance.
    Robertson DS; Choodari-Oskooei B; Dimairo M; Flight L; Pallmann P; Jaki T
    Stat Med; 2023 Jun; 42(14):2496-2520. PubMed ID: 37021359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point estimation for adaptive trial designs I: A methodological review.
    Robertson DS; Choodari-Oskooei B; Dimairo M; Flight L; Pallmann P; Jaki T
    Stat Med; 2023 Jan; 42(2):122-145. PubMed ID: 36451173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point estimation in adaptive enrichment designs.
    Kunzmann K; Benner L; Kieser M
    Stat Med; 2017 Nov; 36(25):3935-3947. PubMed ID: 28783881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial.
    Ji L; McShane LM; Krailo M; Sposto R
    Clin Trials; 2019 Dec; 16(6):599-609. PubMed ID: 31581815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional estimation in two-stage adaptive designs.
    Broberg P; Miller F
    Biometrics; 2017 Sep; 73(3):895-904. PubMed ID: 28099993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point estimation following two-stage adaptive threshold enrichment clinical trials.
    Kimani PK; Todd S; Renfro LA; Stallard N
    Stat Med; 2018 Sep; 37(22):3179-3196. PubMed ID: 29855066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints.
    Di Stefano F; Pannaux M; Correges A; Galtier S; Robert V; Saint-Hilary G
    Stat Med; 2022 May; 41(10):1767-1779. PubMed ID: 35098579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
    Anglemyer A; Horvath HT; Bero L
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interval and point estimation in adaptive Phase II trials with binary endpoint.
    Nhacolo A; Brannath W
    Stat Methods Med Res; 2019 Sep; 28(9):2635-2648. PubMed ID: 29921157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of treatment effect in 2-in-1 adaptive design and some of its extensions.
    Li W; Bai X; Deng Q; Liu F; Chen C
    Stat Med; 2021 May; 40(11):2556-2577. PubMed ID: 33723865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints.
    Meis J; Pilz M; Bokelmann B; Herrmann C; Rauch G; Kieser M
    Stat Med; 2024 Apr; 43(8):1577-1603. PubMed ID: 38339872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using audit information to adjust parameter estimates for data errors in clinical trials.
    Shepherd BE; Shaw PA; Dodd LE
    Clin Trials; 2012 Dec; 9(6):721-9. PubMed ID: 22848072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation after subpopulation selection in adaptive seamless trials.
    Kimani PK; Todd S; Stallard N
    Stat Med; 2015 Aug; 34(18):2581-601. PubMed ID: 25903293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point estimation following a two-stage group sequential trial.
    Grayling MJ; Wason JM
    Stat Methods Med Res; 2023 Feb; 32(2):287-304. PubMed ID: 36384365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.